This study found that certain neutrophils, a type of immune cell, in the lungs of tuberculosis patients have higher metabolic activity, which helps the bacteria survive and thrive. This is important because targeting these metabolic pathways could lead to a new tuberculosis treatment. Senior author Lu Huang, PhD, received a Lung Association Catalyst Award for their work in developing a new tuberculosis vaccine.
Join over 700,000 people who receive the latest news about lung health, including research, lung disease, air quality, quitting tobacco, inspiring stories and more!
Thank you! You will now receive email updates from the American Lung Association.